Management of neuroblastoma in pediatric patients Review

  


Authors: Croteau, N.; Nuchtern, J.; LaQuaglia, M. P.
Review Title: Management of neuroblastoma in pediatric patients
Abstract: Surgeons caring for patients with neuroblastoma must be familiar with recent developments in assessing risk. In particular, the Children's Oncology Group, along with major international groups, uses the International Neuroblastoma Risk Group Staging System as a risk assessment tool. Accurate risk determination is essential for optimal surgical therapy. Some tumors like neonatal adrenal neuroblastomas and those in the metastatic category can be observed. Very-low-risk and low-risk neuroblastomas can be treated with surgery alone. Intermediate-risk tumors also often require systemic chemotherapy © 2020 Elsevier Inc.
Keywords: survival; treatment; staging; neuroblastoma; resection; local control; pediatric surgery; risk status
Journal Title: Surgical Oncology Clinics of North America
Volume: 30
Issue: 2
ISSN: 1055-3207
Publisher: Elsevier Inc.  
Date Published: 2021-04-01
Start Page: 291
End Page: 304
Language: English
DOI: 10.1016/j.soc.2020.11.010
PUBMED: 33706901
PROVIDER: scopus
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100601006&doi=10.1016%2fj.soc.2020.11.010&partnerID=40&md5=0ac10dda36537db851e05a0a2942a9a9
Notes: Review -- Nicole Croteau's first name is listed as Nikke on the original publication -- Export Date: 1 April 2021 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Michael P La Quaglia
    411 La Quaglia
  2. Nicole J Croteau
    10 Croteau
Related MSK Work